Tradestie Institutional Equity Comparison Engine
TMSF vs AAL โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AAL Overall Edge
AAL Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to American Airlines Group Inc. (AAL) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, TMSF trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus AAL at 14.1x Forward P/E and 1.8% operating margin (+19.3% YoY). In options structure, TMSF sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against AAL sits in CONSOLIDATION (16th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
AAL
TMSF N/M vs AAL 14.1x Fwd P/E
Growth & Margin Winner
AAL
Op Margin N/A vs 1.8% ยท YoY N/A vs +19.3%
Momentum & Technical Winner
AAL
1Y -2.4% vs +1.3% ยท 52W Pos 17% vs 36%
Options & Structure Winner
AAL
UNCLASSIFIED (N/A IV) vs CONSOLIDATION (16th %ile IV)
TMSF
US Equity
TMSF
Institutional Equity
$48.88
-0.29% 1D
Market Cap
N/A
1M Return
-0.21%
1Y Return
-2.42%
Forward P/E
N/M
Unified AI Score
43.9 / 100
HOLD
Tech 49.0
Fund 50.0
Flow 50.0
Mom 35.0
AAL
NASDAQ
American Airlines Group Inc.
Air Transportation, Scheduled
$13.24
+0.53% 1D
Market Cap
$8.7B
1M Return
+11.45%
1Y Return
+1.3%
Forward P/E
14.1x
Unified AI Score
53.4 / 100
HOLD
Tech 45.0
Fund 50.0
Flow 57.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
TMSF -2.42%
AAL +1.3%
Spread: +10.59 pp (AAL Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
TMSF TTM Op. Margin: N/A
AAL TTM Op. Margin: 1.8%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on TMSF vs AAL. Trailing 12-month operating profitability (TMSF N/A vs AAL 1.8%) and valuation multiples (TMSF N/M vs AAL 14.1x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | TMSF | AAL | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $8.7B | Larger Scale | AAL |
| Trailing P/E Ratio Valuation | N/M | 11.3x | Lower Multiple | AAL |
| Forward P/E Ratio Valuation | N/M | 14.1x | Lower Multiple | AAL |
| Revenue Growth (YoY) Growth | N/A | +19.3% | Higher Growth | AAL |
| Operating Margin (TTM) Profitability | N/A | 1.8% | Higher Margin | AAL |
| Net Profit Margin Profitability | N/A | -0.8% | Higher Margin | AAL |
| Return on Equity (ROE) Capital Efficiency | N/A | 0.0% | Higher ROE | AAL |
| 52-Week Range Position Momentum | 17% ($48โ$51) | 36% ($10โ$19) | Stronger Trend | AAL |
| Beta / 30D Volatility Risk Regime | 0.14ฮฒ ยท 4% Vol | 1.86ฮฒ ยท 53% Vol | Lower Realized Risk | TMSF |
| Unified Institutional Score Composite Signal | 43.9 / 100 (HOLD) | 53.4 / 100 (HOLD) | Higher Composite | AAL |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full TMSF vs AAL Buy Guide
TMSF
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
AAL
CONSOLIDATION
101d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
16th %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither TMSF nor AAL registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.